Lymphatic Malformations clinical trials

Explore recruiting lymphatic malformations clinical trials.

Recruiting lymphatic malformations studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lymphatic Malformations trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A two-stage double-blind, randomized, placebo-controlled study to assess the efficacy, safety and pharmacokinetics of alpelisib in pediatric and adult patients with lymphatic malformations associated with a PIK3CA mutation

France, Italy, Germany, Spain, Belgium, Netherlands +1 more

Phase II and Phase III (Integrated) EU CTIS Study details

RAPAMALYMPH - Evaluation of the Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations of Poor Prognosis

France

Therapeutic exploratory (Phase II) EU CTIS Study details

TOPical sirolimus in linGUal microkystic lymphatic malformation

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Lymphatic Malformations trials by city

Lymphatic Malformations clinical trials

Recruiting lymphatic malformations studies right now

Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations

Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations

DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia

Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia

A Prospective Study on the Treatment of cLM Based on ICG Imaging

Weekly Sirolimus Therapy

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients

Understanding of Psychotic Disorders in Children With 22q11.2DS

Also recruiting in Europe

A two-stage double-blind, randomized, placebo-controlled study to assess the efficacy, safety and pharmacokinetics of alpelisib in pediatric and adult patients with lymphatic malformations associated with a PIK3CA mutation

RAPAMALYMPH - Evaluation of the Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations of Poor Prognosis

TOPical sirolimus in linGUal microkystic lymphatic malformation

Lymphatic Malformations trials by city

Other conditions